Hanrahan et al., J Clin Oncol 2010
(Lung Neoplasms) :
For example, increases in IL-8 with VCP , MMP-9 with CP, and VEGF with vandetanib monotherapy were associated with increased progression risk, and increase in intercellular adhesion molecule 1 with vandetanib was associated with decreased risk
Kurt-Jones et al., J Immunol 1987
:
Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts